Prognostic impact of residual symptoms at discharge in patients hospitalized for worsening heart failure

Back

ESC2025 Premium Access

Prognostic impact of residual symptoms at discharge in patients hospitalized for worsening heart failure

Session: Novel insight into heart failure

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor Y. Yamada (Yokohama, JP)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Yu Yamada

Yokohama City University Hospital, Yokohama (Japan)

1 follower

6 more presentations in this session

The impact of early SGLT2i inclusion in quadruple therapy for de novo patients: enhancing medication management and clinical outcomes

Speaker: Doctor A. Esteban Fernandez (Leganes, ES)

Current status and characteristics of advance directives in Japanese patients with acute heart failure

Speaker: Doctor K. Takabayashi (Shiga, JP)

Safety and efficacy of Vericiguat 5mg initiation in combination with guideline-directed medical therapy in the treatment of Heart failure with reduced ejection fraction

Speaker: Professor Y. Wang (Changchun, CN)

Oral acetazolamide in acute heart failure: effects on renal function and clinical outcomes

Speaker: Mr J. Gomez Rosero (Medellin, CO)

Characteristics and treatment of patients with heart failure followed in heart failure units in Spain. Differences according to the type of unit.

Speaker: Doctor A. Esteban Fernandez (Leganes, ES)

Access the full session

Novel insight into heart failure

Speakers: Doctor Y. Yamada, Doctor A. Esteban Fernandez, Doctor K. Takabayashi, Professor Y. Wang, Mr J. Gomez Rosero...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources